Great Point Partners LLC Axonics, Inc. Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$35.33 - $51.04 $16.2 Million - $23.5 Million
-459,503 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$22.91 - $39.83 $1.91 Million - $3.32 Million
-83,426 Reduced 15.37%
459,503 $16.1 Million
Q1 2020

May 15, 2020
BUY
$16.44 - $37.73 $1.26 Million - $2.88 Million
76,422 Added 16.38%
542,929 $13.8 Million
Q4 2019

Feb 14, 2020
BUY
$19.57 - $28.96 $9.13 Million - $13.5 Million
466,507 New
466,507 $12.9 Million

Others Institutions Holding AXNX

# of Institutions
234
Shares Held
42.1M
Call Options Held
83.4K
Put Options Held
65.3K
View Full List

About Axonics, Inc.

AXNX Quotes by TradingView
  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email